2-chloroadenosine has been researched along with Fatty Liver in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akimoto, M; Deguchi, S; Furakawa, M; Hashimoto, H; Ishiguro, H; Kato, J; Kawakami, A; Kurihara, T; Maeda, A; Nakano, T; Nakashima, M; Niimi, A; Saniabadi, AR; Shigemoto, M; Tsuchiya, M; Umemura, K; Yamashita, K | 1 |
1 other study(ies) available for 2-chloroadenosine and Fatty Liver
Article | Year |
---|---|
Impaired blood rheology by remnant-like lipoprotein particles: studies in patients with fatty liver disease.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Blood Flow Velocity; Case-Control Studies; Cholesterol; Chromatography, Affinity; Fatty Liver; Hemorheology; Humans; Immunosorbent Techniques; Lipoproteins; Thrombosis; Triglycerides | 2001 |